Literature DB >> 7439196

beta-Thalassemia trait and hyperbilirubinemia in G-6-PD deficient newborn infants.

T Meloni, S Erre, D Gallisai, S Cutillo.   

Abstract

Hb A2 was determined in 50 subjects with erythrocyte G-6-PD deficiency who presented with hyperbilirubinemia in the neonatal period and in 100 non-hyperbilirubinemic G-6-PD deficient newborn infants, at the age of 12 months or more. Six subjects in the first group and 13 in the second were found to be carriers of the beta-thalassemia trait. Statistical analysis of the data did not show any significant difference between the two groups. It seems that the beta-thalassemia trait does not provide any protection against neonatal hyperbilirubinemia associated with G-6-PD deficiency.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7439196     DOI: 10.1007/bf01846028

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  5 in total

1.  Microchromatography of hemoglobins. II. A simplified procedure for the determination of hemoglobin A2.

Authors:  T H Huisman; W A Schroeder; A N Brodie; S M Mayson; J Jakway
Journal:  J Lab Clin Med       Date:  1975-10

2.  Phototherapy for neonatal hyperbilirubinemia in mature newborn infants with erythrocyte G-6-PD deficiency.

Authors:  T Meloni; S Costa; A Dore; S Cutillo
Journal:  J Pediatr       Date:  1974-10       Impact factor: 4.406

3.  Phenobarbital for prevention of hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborn infants.

Authors:  T Meloni; G Cagnazzo; A Dore; S Cutillo
Journal:  J Pediatr       Date:  1973-06       Impact factor: 4.406

4.  alpha-Thalassaemia and hyperbilirubinaemia in G-6-PD-deficient newborns.

Authors:  T Meloni; R Corti; S Costa; G Mele; V Franca
Journal:  Arch Dis Child       Date:  1980-06       Impact factor: 3.791

5.  Methaemoglobin reduction test: a new, simple, in vitro test for identifying primaquine-sensitivity.

Authors:  G J BREWER; A R TARLOV; A S ALVING
Journal:  Bull World Health Organ       Date:  1960       Impact factor: 9.408

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.